Výsledky vyhledávání - "Eric Strobbe"

Abstract PS9-06: Adherence to and patient satisfaction with the combination therapy of exemestane and everolimus in postmenopausal women with HR+ HER2- advanced breast cancer: Results from the IPSOC-mamma study

Publikováno v: Cancer Research. 81:PS9-06

BackgroundEverolimus in combination with exemestane is indicated for the treatment of hormone receptor-positive, HER 2-neg endocrine resistant advanced breast cancer in postmenopausal women. This study investigated treatment adherence, tolerability,

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::66273f2886fe969972e95731b4f4714a
https://doi.org/10.1158/1538-7445.sabcs20-ps9-06

Zobrazit plný text záznamu

6019 POSTER Background and methodology of the ADAGIO study–aprospective, observational, multicenter study to determine the prevalence, predictors, and mediators of non-adherence in patients treated with imatinib

Autor: Ivo Abraham, M. Geelhand, Karen MacDonald, K. Vermeylen, M.A. van Lierde, L. DeRop, Filipo Serra, Stefaan Vancayzeele, S. De Geest, Eric Strobbe

Publikováno v: European Journal of Cancer Supplements. 5:350-351

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::69cf7668b1e3eb5e98e587de37e05382
https://doi.org/10.1016/s1359-6349(07)71310-1

Zobrazit plný text záznamu

Multimethod Clinical Assessment of Patterns and Prevalence of Nonadherence (NA) to Imatinib Treatment (IMRx) in Patients (Pts) with Chronic Myeloid Leukemia (CML): Results from the ADAGIO Study

Autor: Laurie Letvak, Larissa De Rop, Ivo Abraham, Karen MacDonald, Stefaan Vancayzeele, Eric Strobbe, Filipo Serra, Marie-Anne van Lierde, Tara Albrecht, Sabina De Geest

Publikováno v: Blood. 110:5163-5163

BACKGROUND. ImRx for CML is a long-term treatment. Patterns and prevalence of NA to ImRx remain largely unknown. Short-term NA trends may be indicative of long-term NA. Methods for clinical NA assessment vary in reliability. A multimethod approach is

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::fa05f79fe520bd3a3bbaeb9219ba4354
https://doi.org/10.1182/blood.v110.11.5163.5163

Zobrazit plný text záznamu

Promoting Patient (pt) Adherence (PA) with Imatinib Treatment (IMRx) in Chronic Myeloid Leukemia (CML): Physicians (MD) Perceptions of Utility (Effectiveness [FX], Feasibility [FB], Cost [CO]) and Rankings of Clinical Applicability (CAPL) of 13 Adherence-Enhancing Strategies (AESs) - Results from the ADAGIO Study

Autor: Larissa De Rop, Sabina De Geest, Stefaan Vancayzeele, Eric Strobbe, Ivo Abraham, Tara Albrecht, MacDonald MacDonald, Filipo Serra, Marie-Anne van Lierde, Laurie Letvak

Publikováno v: Blood. 110:5165-5165

BACKGROUND. Patterns, prevalence, and associated pt variables of CML pts’ nonadherence (PNA) with ImRx are being better understood. Reducing ImRx PNA may impact on treatment outcomes. Various AESs have been proposed but their perceived value and cl

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::89d0f064c0025447eef133cce27e0fce
https://doi.org/10.1182/blood.v110.11.5165.5165

Zobrazit plný text záznamu

Canonical Correlation Analysis (CCA) of Imatinib Treatment (ImRx) Nonadherence (NA) with Associated Patient Variables (APVs) in Chronic Myeloid Leukemia (CML) - Results from the ADAGIO Study

Autor: Stefaan Vancayzeele, Eric Strobbe, Filipo Serra, Tara Albrecht, Laurie Letvak, Karen MacDonald, Larissa De Rop, Ivo Abraham, Sabina De Geest, Marie-Anne van Lierde

Publikováno v: Blood. 110:5164-5164

BACKGROUND. ImRx for CML is a long-term treatment potentially compromised by NA. Identifying APVs may assist in reducing NA and optimizing treatment outcomes. OBJECTIVE. To model the relationships between two NA measures and selected APVs using CCA,

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::e7da8f0da80f7e5ff6bf049d1cc1030c
https://doi.org/10.1182/blood.v110.11.5164.5164

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání